Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Completed · Phase 2 · Has a placebo group

Conditions studied: Nonalcoholic Steatohepatitis (NASH)

In brief

The purpose of this study is to determine the safety, tolerability, and efficacy of NGM282 in patients with nonalcoholic steatohepatitis.

Key facts

Study ID

NCT02443116

Run by

NGM Biopharmaceuticals, Inc

People needed

254

Starts

2015-07-31

Expected to finish

2020-01-17

Last updated by the study team

2025-07-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females, between 18 and 75 years of age, inclusive
• Histologically confirmed NASH diagnosis

You may not qualify if…

• Clinically significant acute or chronic liver disease
• Prior liver transplantation

Where it is running

• NGM Clinical Study Site 922 — Chandler, Arizona, United States
• NGM Clinical Study Site 923 — Tucson, Arizona, United States
• NGM Clinical Study Site 924 — Los Angeles, California, United States
• NGM Clinical Study Site 901 — San Diego, California, United States
• NGM Clinical Study Site 902 — Denver, Colorado, United States
• NGM Clinical Study Site 917 — Lakewood Rch, Florida, United States
• NGM Clinical Study Site 906 — Chicago, Illinois, United States
• NGM Clinical Study Site 918 — Kansas City, Missouri, United States
• NGM Clinical Study Site 903 — Durham, North Carolina, United States
• NGM Clinical Study Site 921 — Germantown, Tennessee, United States
• NGM Clinical Study Site 910 — Dallas, Texas, United States
• NGM Clinical Study Site 920 — Rollingwood, Texas, United States
• NGM Clinical Study Site 909 — San Antonio, Texas, United States
• NGM Clinical Study Site 905 — San Antonio, Texas, United States
• NGM Clinical Study Site 904 — Charlottesville, Virginia, United States
• NGM Clinical Study Site 911 — Richmond, Virginia, United States
• NGM Clinical Study Site 908 — Seattle, Washington, United States
• NGM Clinical Study Site 703 — Sydney, New South Wales, Australia
• NGM Clinical Study Site 704 — Adelaide, South Australia, Australia
• NGM Clinical Study Site 701 — Melbourne, Victoria, Australia
• NGM Clinical Study Site 705 — Melbourne, Victoria, Australia
• NGM Clinical Study Site 916 — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.